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Abstract 
The forensic utility of fatty acid ethyl esters (FAEEs) in dried blood spots (DBS) as short-term confirmatory markers 
for ethanol intake was examined. An LC-MS/MS method for the determination of FAEEs in DBS was developed and 
validated to investigate FAEE formation and elimination in a drinking study, wherebyeight subjects ingested 0.66 to 
0.84g/kg alcohol to reach blood alcohol concentrations (BAC) of 0.8g/kg. Blood was taken every 1.5-2 hours, BAC 
was determined and dried blood spots were prepared, with 50 microliters of blood, for the determination of 
FAEEs.Lower limits of quantitation (LLOQ) were between 15 ng/mL and 37ng/mL for the four major FAEEs. 
Validation data are presented in detail. In the drinking study, ethyl palmitate and ethyl oleate proved to be the two 
most suitable markers for FAEE determination. Maximum FAEE concentrations were reached in samples taken 2 or 
4 hours after the start of drinking. The following mean peak concentrations (c̅max) were reached: ethyl myristate 
14±4ng/mL, ethyl palmitate 144±35ng/mL, ethyl oleate 125±55ng/mL, ethyl stearate 71±21ng/mL, total FAEEs 
344±91ng/mL. Detectability of FAEEs was found to be on the same timescale as BAC. In liquid blood samples 
containing ethanol, FAEE concentrations increase post-sampling. –This study shows, that the use of DBS fixation 
prevents additional FAEE formation in blood samples containing ethanol. Positive FAEE results obtained by DBS 
analysis can be used as evidence for the presence of ethanol in the original blood sample. 
Keywords. - FAEE, Fatty Acid Ethyl Ester, Alcohol Marker, Abstinence Monitoring, Whole Blood, LC-MS/MS, 
Dried Blood Spots 
  
Introduction 
Alcohol abuse and its medical and social effects pose a major challenge in today’s society. In order to prove alcohol 
abstinence, various secondary alcohol markers are currently analyzed in blood, urine, and hair, such as ethyl 
glucuronide (EtG), ethylsulfate (EtS) and phosphatidylethanol (PEth) [1]. Fatty acid ethyl esters are non-oxidative 
short-time metabolites that are generally not included in routine analysis [2]. FAEE metabolites are detectable in 
blood when ethanol is present and up to 24 hours after alcohol intake [3]. FAEE formation is mainly catalyzed by 
FAEE synthases and acyl-CoA: ethanol O-acyltransferases (AEAT), which form fatty acid ethyl esters by 
esterification of ethanol with endogenous fatty acids or fatty acyl-CoA. Based on their chemical structure, FAEEs 
have a tendency to bind to albumin and lipoproteins, both of which serve as transporters between different lipid 
compartments. Although at least 15 different FAEEs have been identified in the human body, four FAEEs in 
particular are used as ethanol consumption-related markers: ethyl myristate (14:0), ethyl palmitate (16:0), ethyl 
stearate (18:0) and ethyl oleate (18:1). Until recently, the detection of FAEEs was predominantly based on GC/MS 
and SPME-GC/MS methods for hair samples and meconium, whereby the total FAEE concentration was summed up 
[1, 2]. Analysis of FAEEs by using LC-MS/MS was first published in 2014, whereby in utero ethanol exposure in 
meconium was identified [4]. This paper provides detailed profiles of the four particular FAEE during a drinking 
study and can be compared to the work of Doyle et al. [3], where the total FAEE concentration in relation to the 
blood alcohol concentration was investigated. However, our DBS method prevents FAEE formation post-sampling 
and exhausts the potential of present-day instrumentation by using low sample volume. LC-MS/MS was the method 
of choice, as SPME-GC/MS and GC/MS could not provide the required sensitivity, when only using microliter 
amounts of blood. Furthermore, endogenous fatty acid concentrations were detected and quantified by using linear 
regression.  
Materials and Methods 
Reagents 
Ethyl myristate, ethyl palmitate, and ethyl stearate were purchased from Lipomed (Arlesheim, Switzerland). Ethyl 
oleate (98%) was obtained from Sigma Aldrich (Buchs, Switzerland). Pentadeuterated internal standards, D5-ethyl 
myristate, D5-ethyl palmitate, D5-ethyl stearate and D5-ethyl oleate were ordered from Toronto Research Chemicals 
(Toronto, Canada). Acetonitrile (MeCN) HPLC for gradient analysis was purchased from Acros Organics (New 
Jersey, USA) and water was produced in-house with a Milli-Q water system from Millipore (Billerica, USA). Dried 
dimethyl sulfoxide (DMSO) (max. 0.05% H2O, purity ≥99.5%) and EMSURE® n-heptane for analysis (>99%) were 
obtained from Merck (Darmstadt, Germany). Pure ethanol HPLC grade was obtained from Merck (Darmstadt, 
Germany). Formic acid puriss. p.a. for HPLC (50% in water) and Whatmann® #903 CF12® protein saver paper 
were ordered from Sigma Aldrich (Buchs, Switzerland). Anticoagulant citrate phosphate dextrose (CPD) treated 
blank whole blood for the calibration and the quality control samples was delivered from the local blood collection 
center (Bern, Switzerland). The anticoagulant lithium heparin was used to obtain whole blood samples during the 
drinking study. 
Study Design 
Eight volunteers (6 men, 2 women, aged 19 to 26 years), who had been abstinent for at least two weeks, ingested a 
single dose of alcohol (66-proof/37.5% vodka mixed with a soft drink), which led to an approximate BAC of 0.8 
g/kg. The alcohol doses (125-210mL) were calculated for each test person by the Widmark formula with individually 
adjusted reduction factors based on the weight and size of the individual [5]. Blank blood samples were obtained 
from all subjects prior to the experiment. 100 minutes after the start of drinking, the first blood sample was taken. 
Three more samples were taken during the next 5 hours. All blood samples were directly spotted on protein saver 
filter paper to create DBS.  
  
Sample Preparation 
FAEEs were analyzed in DBS generated from lithium-heparinized blood by spotting 50 µL of blood onto a 
Whatmann
®
 #903 CF12
®
 protein saver paper. Before extraction, the DBS were dried at room temperature for at least 
3 hours.  
Determination of BAC 
BAC was determined in lithium-heparinized blood in house by a validated headspace gas chromatography method 
with flame ionization detection (HS-GC-FID). According to Swiss forensic guidelines, the samples were analyzed 
with two GC-FID systems with two measurements each, analogously to BAC determination in serum [6].  
Determination of FAEEs 
For analyzing ethyl myristate (C14), ethyl palmitate (C16), ethyl oleate (C18:1), and ethyl stearate (C18), a DBS 
generated  from 50 µL of blood was cut out and 20 µL of internal standard (D5-ethyl myristate (C14) 75 ng/mL, D5-
ethyl palmitate (C16) 62.5 ng/mL, D5-ethyl oleate (C18:1) 125 ng/mL, and D5-ethyl stearate (C18) 62.5 ng/mL), 500 
µL of DMSO and 1000 µL n-heptane were pipetted into a micro tube and mixed for 20 minutes at 1500 rpm on a 
VIBRAX VXR basic from IKA (Staufen, Germany). Afterwards, the samples were centrifuged for 10 min at 16’000 
g. The samples were placed in the freezer at about -18°C for 30 minutes to congeal the DMSO and simplify the 
transfer of the supernatant to a 1.5 mL snap/crimp champagne glass vial. The organic phase was evaporated until dry 
at 60°C under vacuum (approximately 180 mbar) with a CentriVap concentrator from LABCONCO
®
 (Biolabo 
Scientific Instruments, Switzerland). The residue was dissolved in 300 µL acetonitrile. An aliquot of 5 µL was 
injected into the LC-MS/MS system. A blank (whole blood from an abstinent person without internal standard) and a 
zero sample (whole blood from an abstinent person with internal standard) were always included. 
FAEE in vitro production 
5 mL of fresh, lithium heparinized blood was spiked immediately after sampling with 6.3 µL, 12.6 µL, and 18.9 µL 
ethanol to obtain a BAC of 1, 2, and 3 g/kg (±0.05g/kg), respectively. After spiking, the blood was incubated at 37°C 
and a 50 µL DBS was generated every ten minutes during the first hour to monitor FAEE production. The blank 
sample at t = 0 did not contain any alcohol.  
Method validation 
Method validation for the determination of FAEEs in DBS was performed according to FDA guidelines with a 
standard addition correction for endogenous levels [7]. Selectivity, linearity, limit of quantification, imprecision 
(expressed as the relative standard deviation (RSD%)), accuracy (expressed as the mean relative error (RE%), and 
carry–over were investigated. Selectivity was determined by testing six blank samples of blood from alcohol 
abstinent people (abstinence period of more than 2 weeks) and from swine for interferences of endogenous matrix 
components or metabolites, which could disturb the signals of FAEEs or internal standards. Additionally, the 
feasibility of a standard addition-based method was investigated, by using blank blood from an abstinent subject. 
CPD treated blood from an abstinent person was used for calibration and quality control samples. Working solutions 
containing all four FAEEs (0.2, 0.4, 1, 2, 5, 10, 15, 20, and 40 µg/mL) for the calibration samples were prepared in 
acetonitrile and 10 µL of each were spiked in 190 µL of blank blood. The calibrators had the following 
concentrations: 10, 20, 50, 100, 250, 500, 750, 1000, and 2000 ng/mL. Nine-point calibration curves of FAEEs were 
recorded twice on three different days. Precision and accuracy were determined by preparing blood samples (quality 
control samples, QC) spiked at different FAEE concentration levels: 10, 20, 30, 50, 150, 600, and 1500 ng/mL. 
Carry-over was measured by injecting the highest calibrator (2000 ng/mL) three times, followed by a blank blood 
sample in duplicate to test if substances from the previous injection were carried over to the next measurement. 
Matrix effects, recovery, and extraction efficiency were analyzed by post extraction addition. Corrections for 
endogenous FAEE concentrations were made at the end of the measurement by correcting for the absolute value of 
the x-axis intercept from the individual calibration curve. 
Instrumentation 
The LC-MS/MS system was composed of an UltiMate
®
 3000 UHPLC+ focused system with an UltiMate
®
 3000 RS 
autosampler and a heated column compartment from Dionex (Olten, Switzerland) with a QTrap 5500 mass 
spectrometer from Sciex (Toronto, Canada), controlled by Analyst 1.6.2 software. Chromatographic separation was 
performed with a core-shell Kinetex 2.6 µ, C8, 100 å, 50×2.1 mm column from Phenomenex (Torrance, USA), 
heated at 40°C, with a flow rate of 0.5 mL/min. Mobile phase A consisted of water with 0.1% formic acid, mobile 
phase B consisted of acetonitrile with 0.1% formic acid. The FAEEs, depicted in table 1, were analyzed with the 
following 8 min gradient: 0 to 0.5 min, 20% B; 0.5 to 1.5 min, 20 to 70% B linear; 1.5 to 5 min, 70 to 97.5% B 
linear; 5 to 6 min, 97.5% B; 6 to 6.1 min 97.5 to 20% B linear, 6.1 to 8 min, 20% B. The mass spectrometer was 
operated in electrospray positive MRM mode with an ion spray voltage of 5000V and a source temperature of 650°C, 
collision gas at medium 40, curtain gas: 40, gas1: 40, gas 2: 40.  
Table 1.- MS/MS parameters and retention time for FAEEs quantitation from DBS. 
Analyte Q1 [m/z] Q3 [m/z] Time [msec] DP [volts] CE [volts] CXP [volts] RT [min] 
Ethyl Myristate  
  
  
257.2 229.2 30 85 15 20 3.27 
257.2 103 30 85 22 12 
257.2 247.2 30 85 10 22 
Ethyl Myristate-d5  262.2 230.3 20 81 15 16 3.26 
Ethyl Palmitate  285.1 257.3 30 41 15 22 3.74 
285.1 71.1 30 41 21 34 
Ethyl Palmitate-d5  290.3 258.4 20 86 17 12 3.72 
Ethyl Oleate 311.2 265.3 30 100 15 24 3.86 
311.2 247.2 30 100 17 20 
Ethyl Oleate-d5  316.3 265.4 20 86 15 22 3.84 
Ethyl Stearate 313.1 285.3 30 46 17 22 4.21 
313.1 71.1 30 36 25 10 
Ethyl Stearate-d5 318.3 286.2 20 56 17 22 4.20 
 
  
Results and Discussion 
Method Validation 
Regarding selectivity, the measured samples had to be corrected for endogenous FAEE concentrations to obtain valid 
results, as there was no blood available which did not contain any FAEEs. Extracted ion chromatograms for a blank 
blood specimen and a calibrator (K3, 50ng/mL) are shown in figure 1The endogenous FAEE levels of 14 abstinent 
individuals proved to be close to each other (total FAEEs 40-67 ng/mL), swine blood contained larger amounts of 
FAEEs (total FAEEs 190 ng/mL) and could therefore not be used as blank blood. To analyze the linearity of the 
developed method, a linear calibration model with weighting 1/x
2
 was used with spiked concentrations in the range 
of 10-2000 ng/mL. Extracted ion chromatograms for MRM1, MRM2 and internal standards are shown in figure 2. 
All calibration curve correlation coefficients (R
2
) from least square regression were >0.994. With respect to the mean 
endogenous concentration from the validation measurements, lowest calibrator (10 ng/mL) for ethyl myristate, ethyl 
palmitate, and ethyl oleate, and 20 ng/mL for ethyl stearate fulfilled the validation criteria. The following LLOQ 
were established after the correction for endogenous FAEE concentrations by linear regression: ethyl myristate 15 
ng/mL, ethyl palmitate 26 ng/mL, ethyl oleate 14 ng/mL, ethyl stearate 37 ng/mL. The limit of detection (LOD) was 
not established, as the samples are corrected for endogenous levels by the standard addition procedure. Imprecision 
and accuracy were in acceptable ranges. All QC samples had measured concentrations within ±15% of target, in 
accordance with FDA guidelines [7]. Mean intra assay accuracy was 89.1-108.9% and mean inter assay accuracy 
94.1-110.7% of target. Intra assay imprecision was 1.3-14.6% and inter assay imprecision 0.6-14.3% (Supplementary 
Data, Table S1. 
 
Figure 1.- Typical chromatogram of blank whole blood (a) and whole blood spiked with K3 (50ng/mL) (b). MRM1: ethyl 
myristate (blue), ethyl palmitate (red), ethyl oleate (green), and ethyl stearate (grey). 
 Figure 2.- Detailed chromatogram for ethyl myristate (a), ethyl palmitate (b), ethyl oleate (c), and ethyl stearate (d) at 
concentration K3 with MRM1 (blue), MRM2 (red) and internal standard (green) 
No evidence for carry-over was found. All FAEEs demonstrated adequate extraction efficiency of 40-69%, recovery 
was 40-75%, FAEE matrix effects were 93-113%, depicted in Table 2. Extracted samples were stable up to 72 hours 
in the autosampler, after 3 freeze thaw cycles at about -18°C, and after storage for 7 days at about -18°C. However, 
after extraordinarily long storage (7 days) at room temperature, quality control samples (prepared as DBS) showed a 
large variation of measured concentrations, compared to samples prepared and analyzed on day 0. QC showed 
increases (up to 41%) and decreases (up to -52%) of the FAEE concentrations. This finding implies that the long-
term stability of analytes has to be taken into account. DBS samples collected during the drinking study were within 
±13% of immediate measurement when extracted after one week of storage (samples & calibrators stored at room 
temperature). Due to the observed instability, DBS were extracted within 24 hours after their generation. 
Furthermore, samples which were analyzed and compared together (quality control, calibration, drinking study) were 
always prepared and extracted simultaneously.  
Table 2.- Extraction efficiency, recovery and matrix effect for FAEEs in DBS 
a
 low QC concentration was 50 ng/mL for all FAEEs.  
b
 high QC concentration was 600 ng/mL for all FAEEs. 
 extraction efficiency (n=2) recovery (n=2) matrix effect (n=2) 
Analyte low
a
 high
b
 low high low high 
ethyl myristate 40% 45% 40% 42% 99% 93% 
ethyl palmitate 55% 60% 51% 63% 93% 105% 
ethyl oleate 59% 61% 55% 62% 96% 101% 
ethyl stearate 59% 69% 67% 75% 113% 110% 
 
In vitro FAEE production 
After the addition of ethanol, FAEE levels above the LLOQ were obtained for all four FAEEs. The biggest alcohol 
concentration-related increase in FAEE concentration was observed for ethyl palmitate and ethyl oleate. After thirty 
minutes, FAEE concentrations above the LLOQ were reached for all concentrations of alcohol. Ethyl stearate 
concentrations above the LLOQ were found for samples containing at least 2 g/kg of BAC and after 210 minutes 
only. Ethyl myristate showed concentrations above the LLOQ for all three alcohol concentrations after 50 minutes, 
whereby no distinction was possible concerning the alcohol concentration spiked to the sample. Detailed time 
courses for the increase in in vitro FAEE concentrations are shown in figure 3. This in vitro experiment clearly 
demonstrated the necessity of immediate DBS fixation to measure FAEE concentrations reliably. 
 
Fig 3.- Time courses for in vitro fatty acid ethyl ester (FAEE) concentrations for the four investigated 
substances over a time period of 210 minutes after spiking the blood for BAC of 1, 2 and 3 g/kg. 
  
Drinking study results 
The group of participating volunteers was very homogenous in age and body mass index (BMI) with a mean age of 
23.5±2.4 years (range: 19-26 years) and a BMI of 21.3±2.5 kg/m
2
 (range: 17.7-25.1 kg/m
2
). All blood samples 
collected prior to drinking were tested negative for ethanol and below or close to the LLOQ for all FAEEs. 
Maximum BACs were reached 1.75 hours after the start of drinking with a mean maximum BAC of 0.76±0.06 g/kg 
(range: 0.66-0.84 g/kg). After drinking the calculated amounts of vodka, the following mean maximal concentrations 
were reached: ethyl myristate c̅max =14±4 ng/mL, ethyl palmitate c̅max =144±35 ng/mL, ethyl oleate c̅max =125±55 
ng/mL, and ethyl stearate c̅max =71±21 ng/mL, total FAEEs c̅max =344±91 ng/mL. Figure 4 shows the time courses of 
each subject. There was a significant overlap between the curves for BAC and FAEE concentration over the time 
course. The peak of the BAC and FAEE concentrations were found to be very close. Subject 1-7 showed similar 
FAEE profiles, subject 8 showed a delayed FAEE formation. As shown in the in vitro experiments, FAEE formation 
started immediately after alcohol ingestion and increased to a maximum during the first four hours. After 4 hours the 
concentration of FAEEs in the blood decreased. FAEE concentrations around the LLOQ were observed after 7 hours, 
when BAC reached zero. Although the concentrations for all FAEEs in all the subjects’ samples increased after the 
consumption of alcohol, only 5 participants reached ethyl myristate levels above the LLOQ. Ethyl palmitate and 
ethyl oleate showed the highest increase. In comparison, ethyl stearate, with a relatively high LLOQ of 37 ng/mL, 
showed concentrations above the LLOQ only for a short time. Detailed time courses for BAC and FAEE 
concentrations in different subjects are depicted in figure 4. FAEE concentrations above the endogenous level were 
not detected after 24 or 48 hours.  
 Fig 4.- Time courses for fatty acid ethyl ester (FAEE) concentrations in DBS and ethanol concentration for 
subject 1-8 over a period of 7 hours. Ethanol ingestion occurred during the first hour of the time course. 
Conclusion 
The results of this study indicate that whole blood DBS FAEE analysis may be useful as a short-term confirmation 
for ethanol ingestion or in the absence of liquid samples (e.g. blood spots in crime scenes). However, matrix samples 
without blood contamination would need further investigation (as a control sample) and further method validation 
would be necessary[8]. Especially during PEth analysis [9, 10], where DBS fixation proved to be beneficial to 
prevent in vitro formation, FAEE analysis could serve as a second alcohol marker to monitor recent alcohol 
consumption. The detectability of FAEE concentrations in blood was found to be very similar to those of ethanol. A 
terminal half-life, which would allow a detection for up to 24 hours [3] was not found with a target BAC of 0.8 g/kg. 
Endogenous FAEE concentrations were observed and quantified using standard addition method. Ethyl palmitate and 
ethyl oleate appeared to be the two most useful FAEE, as concentrations above the LLOQ are easily reached. The 
application of DBS in FAEE analysis provides a safe and easy method to inhibit in vitro FAEE formation. 
Furthermore extraction is simplified when using DBS, as no time-consuming SPE is needed, compared to analysis in 
blood serum with GC-MS [3]. The use of a LC-MS/MS method proved to be beneficial compared to preliminary 
tests with GC-MS [3] and SPME-GC/MS [11] methods, which could not provide the same sensitivity. In addition, 
the run-time of a LC-MS/MS measurement (eight minutes) is about four times faster than a SPME-GC/MS method 
(extraction of 20-30 minutes and analysis of 10 minutes). [12] Further studies are necessary to investigate the 
relationship between blood fatty acid content and the formation of FAEEs. 
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Supplementary Data 
Table 3.- Mean accuracy and imprecision results for FAEEs in DBS at 7 quality control concentrations. 
Analyte 
concentration 
(ng/mL) 
intra assay 
accuracy 
(%, n=6) 
inter assay 
accuracy 
(%, n=3) 
intra assay 
imprecision 
(%, n=6) 
inter assay 
imprecision 
(%, n=3) 
ethyl myristate 
10 99.5 106.6 3.7 11.0 
20 108.9 110.7 2.8 6.0 
30 106.0 107.6 1.3 2.3 
50 100.4 104.8 2.5 3.8 
150 100.7 104.0 3.0 4.9 
600 100.3 104.4 3.6 4.0 
1500 102.7 105.1 3.1 2.6 
ethyl palmitate 
10 89.1 94.1 4.7 6.2 
20 94.0 104.5 5.2 14.3 
30 101.6 101.5 3.7 5.2 
50 106.8 106.9 6.7 4.4 
150 98.7 97.9 3.8 4.2 
600 98.1 98.2 4.7 4.8 
1500 102.0 100.5 3.2 1.5 
ethyl oleate 
10 98.5 104.0 8.8 10.0 
20 102.8 101.3 5.4 3.3 
30 108.1 102.8 3.6 4.9 
50 105.0 105.5 6.1 8.5 
150 99.9 99.8 3.3 0.6 
600 98.6 100.8 2.3 12.0 
1500 100.4 100.0 2.5 1.7 
ethyl stearate 
20 99.6 99.0 13.8 8.3 
30 105.0 99.2 4.3 5.1 
50 104.5 96.8 14.6 7.0 
150 99.4 99.3 4.6 2.3 
600 99.3 97.9 3.3 1.8 
1500 101.8 99.7 5.2 3.0 
 
 
